JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lands, A. M.
Right arrow Articles by Luduena, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lands, A. M.
Right arrow Articles by Luduena, F. P.
Journal of Pharmacology And Experimental Therapeutics, Vol. 116, Issue 2, 177-190, 1956
Copyright © 1956 by American Society for Pharmacology and Experimental Therapeutics


THE CHOLINOLYTIC ACTION OF SUBSTITUTED DIALKYLAMINOALKANES AND DIALKYLAMINOALKANOLS

A. M. Lands 1 and F. P. Luduena 1

1 Pharmacology Section, Sterling-Winthrop Research Institute, Rensselaer, New York

Potent cholinolytic (anticholinergic) action has been demonstrated in a series of dialkylaminoalkanols. The methohalide salts are significantly more effective than the corresponding hydrochlorides. The presence of a hydroxy substitution on the terminal carbon contributes importantly to cholinolytic potency. In addition, the presence of an umbrella-like mass obtained by varied substitutions on the terminal carbon also contributes to this activity. Although varied, the substituents which characterize the most potent compounds suggest that there is some degree of structural specificity involved.

The results of this investigation and that of previous ones carried out in our laboratories, and discussed in this communication, suggest the following generalizations. Post-ganglionic parasympathetic fibers of the autonomic nervous system supply a single type of receptor which has the characteristics of a crevice or trough-like structure in which the active cholinolytic drug is held by electrostatic attraction to an anionic area by the cationic head and by a second point of attachment to the receptor through a hydroxy (polar) group, this latter being at a distance of 4-7 Aring; from the cationic head. The overall length of the reactive receptor surface is about 7-8 Å, measured from the anionic site.

Quaternization of the amine with a methyl- or ethylhalide increases cholinolytic potency, possibly by providing a more favorable fit to the receptor site (a near optimal stereochemical change) and/or by increasing the electrostatic charge on the nitrogen. This change in the cationic group increases toxicity but there appears to be no direct correlation between the observed cholinolytic action and the toxic effects.

Submitted on August 29, 1955







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1956 by the American Society for Pharmacology and Experimental Therapeutics.